loadpatents
name:-0.071569919586182
name:-0.054872989654541
name:-0.039248943328857
Campbell; Ann-Marie Patent Filings

Campbell; Ann-Marie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Campbell; Ann-Marie.The latest application filed is for "pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors".

Company Profile
44.56.69
  • Campbell; Ann-Marie - Monroe CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors
App 20220033403 - Ioannidis; Stephanos ;   et al.
2022-02-03
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors
App 20210332052 - Ioannidis; Stephanos ;   et al.
2021-10-28
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20210323978 - Ioannidis; Stephanos ;   et al.
2021-10-21
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20210292337 - Ioannidis; Stephanos ;   et al.
2021-09-23
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20210130321 - Ioannidis; Stephanos ;   et al.
2021-05-06
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
Grant 10,981,915 - Ioannidis , et al. April 20, 2
2021-04-20
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20210078973 - Lin; Jian ;   et al.
2021-03-18
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
Grant 10,934,299 - Ioannidis , et al. March 2, 2
2021-03-02
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
Grant 10,927,130 - Ioannidis , et al. February 23, 2
2021-02-23
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
Grant 10,906,916 - Ioannidis , et al. February 2, 2
2021-02-02
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,889,567 - Lin , et al. January 12, 2
2021-01-12
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,836,741 - Ioannidis , et al. November 17, 2
2020-11-17
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Grant 10,807,976 - Lin , et al. October 20, 2
2020-10-20
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20200223822 - Lin; Jian ;   et al.
2020-07-16
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20200115343 - Lin; Jian ;   et al.
2020-04-16
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20200087280 - Ioannidis; Stephanos ;   et al.
2020-03-19
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,577,329 - Lin , et al.
2020-03-03
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Grant 10,550,099 - Lin , et al. Fe
2020-02-04
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,550,098 - Lin , et al. Fe
2020-02-04
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors
App 20200010464 - Lin; Jian ;   et al.
2020-01-09
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,519,127 - Ioannidis , et al. Dec
2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,519,129 - Ioannidis , et al. Dec
2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,519,130 - Ioannidis , et al. Dec
2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,519,128 - Ioannidis , et al. Dec
2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,513,508 - Ioannidis , et al. Dec
2019-12-24
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,513,507 - Ioannidis , et al. Dec
2019-12-24
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 10,508,098 - Ioannidis , et al. Dec
2019-12-17
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors
App 20190367525 - Ioannidis; Stephanos ;   et al.
2019-12-05
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190359635 - Ioannidis; Stephanos ;   et al.
2019-11-28
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190359629 - Ioannidis; Stephanos ;   et al.
2019-11-28
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190308980 - Ioannidis; Stephanos ;   et al.
2019-10-10
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,414,752 - Lin , et al. Sept
2019-09-17
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Grant 10,407,419 - Lin , et al. Sept
2019-09-10
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190263779 - Lin; Jian ;   et al.
2019-08-29
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190263778 - Lin; Jian ;   et al.
2019-08-29
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
Grant 10,377,773 - Ioannidis , et al. A
2019-08-13
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
Grant 10,377,767 - Ioannidis , et al. A
2019-08-13
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
Grant 10,377,760 - Ioannidis , et al. A
2019-08-13
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
Grant 10,351,571 - Ioannidis , et al. July 16, 2
2019-07-16
Phenyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190210970 - Lin; Jian ;   et al.
2019-07-11
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190210995 - Lin; Jian ;   et al.
2019-07-11
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190202790 - Lin; Jian ;   et al.
2019-07-04
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,294,206 - Lin , et al.
2019-05-21
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190135781 - Lin; Jian ;   et al.
2019-05-09
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Grant 10,280,150 - Lin , et al.
2019-05-07
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,266,495 - Lin , et al.
2019-04-23
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,253,015 - Lin , et al.
2019-04-09
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190071421 - Ioannidis; Stephanos ;   et al.
2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190071419 - Ioannidis; Stephanos ;   et al.
2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190071420 - Ioannidis; Stephanos ;   et al.
2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190071418 - Ioannidis; Stephanos ;   et al.
2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190071423 - Ioannidis; Stephanos ;   et al.
2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20190071422 - Ioannidis; Stephanos ;   et al.
2019-03-07
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20180346480 - Ioannidis; Stephanos ;   et al.
2018-12-06
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20180346485 - Ioannidis; Stephanos ;   et al.
2018-12-06
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors
App 20180339991 - Ioannidis; Stephanos ;   et al.
2018-11-29
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors
App 20180339988 - Ioannidis; Stephanos ;   et al.
2018-11-29
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180327382 - Lin; Jian ;   et al.
2018-11-15
Phenyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180327361 - Lin; Jian ;   et al.
2018-11-15
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180312487 - Lin; Jian ;   et al.
2018-11-01
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,005,734 - Lin , et al. June 26, 2
2018-06-26
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
Grant 10,000,495 - Ioannidis , et al. June 19, 2
2018-06-19
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20180162835 - Ioannidis; Stephanos ;   et al.
2018-06-14
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180141910 - Lin; Jian ;   et al.
2018-05-24
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Grant RE46,856 - Hentemann , et al. May 22, 2
2018-05-22
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180134682 - Lin; Jian ;   et al.
2018-05-17
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180118732 - Lin; Jian ;   et al.
2018-05-03
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
Grant 9,938,300 - Ioannidis , et al. April 10, 2
2018-04-10
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
Grant 9,932,351 - Ioannidis , et al. April 3, 2
2018-04-03
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180086733 - Lin; Jian ;   et al.
2018-03-29
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
Grant 9,902,728 - Ioannidis , et al. February 27, 2
2018-02-27
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
Grant 9,840,491 - Ioannidis , et al. December 12, 2
2017-12-12
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 9,834,539 - Lin , et al. December 5, 2
2017-12-05
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Grant 9,815,817 - Lin , et al. November 14, 2
2017-11-14
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 9,771,349 - Lin , et al. September 26, 2
2017-09-26
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20170174658 - LIN; Jian ;   et al.
2017-06-22
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 9,624,175 - Lin , et al. April 18, 2
2017-04-18
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Grant 9,624,216 - Lin , et al. April 18, 2
2017-04-18
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160311818 - Lin; Jian ;   et al.
2016-10-27
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160311774 - Lin; Jian ;   et al.
2016-10-27
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20160229864 - Ioannidis; Stephanos ;   et al.
2016-08-11
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors
App 20160229872 - Ioannidis; Stephanos ;   et al.
2016-08-11
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors
App 20160229833 - Ioannidis; Stephanos ;   et al.
2016-08-11
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors
App 20160185785 - Ioannidis; Stephanos ;   et al.
2016-06-30
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors
App 20160185786 - Ioannidis; Stephanos ;   et al.
2016-06-30
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083367 - Lin; Jian ;   et al.
2016-03-24
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083366 - Lin; Jian ;   et al.
2016-03-24
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083349 - Lin; Jian ;   et al.
2016-03-24
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083365 - Lin; Jian ;   et al.
2016-03-24
Uses of substituted imidazoheterocycles
Grant 8,859,538 - Beckett , et al. October 14, 2
2014-10-14
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis
App 20130261113 - HENTEMANN; Martin ;   et al.
2013-10-03
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Grant 8,466,283 - Hentemann , et al. June 18, 2
2013-06-18
Substituted imidazoheterocycles
Grant 8,431,565 - Beckett , et al. April 30, 2
2013-04-30
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
Grant 8,013,166 - Smith , et al. September 6, 2
2011-09-06
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
Grant 7,968,576 - Smith , et al. June 28, 2
2011-06-28
Preparation And Use Of Biphenyl-4-yl-carbonylamino Acid Derivatives For The Treatment Of Obesity
App 20110118302 - Smith; Roger ;   et al.
2011-05-19
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
App 20110083984 - Hentemann; Martin ;   et al.
2011-04-14
Uses Of Substituted Imidazoheterocycles
App 20110034443 - Beckett; R. Paul ;   et al.
2011-02-10
Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
Grant 7,759,376 - Smith , et al. July 20, 2
2010-07-20
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
App 20090270468 - Smith; Roger ;   et al.
2009-10-29
Preparation And Use Of Aryl Alkyl Acid Derivatives For The Treatment Of Obesity
App 20090253762 - Smith; Roger ;   et al.
2009-10-08
Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity
App 20090215780 - Smith; Roger ;   et al.
2009-08-27
Preparation And Use Of Aryl Alkyl Acid Derivatives For The Treatment Of Obesity
App 20090197795 - Smith; Roger ;   et al.
2009-08-06
Substituted Imidazoheterocycles
App 20090149450 - Beckett; R. Paul ;   et al.
2009-06-11
Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor agonists for the treatment of pain
Grant 7,517,874 - Beckett , et al. April 14, 2
2009-04-14
Substituted Imidazoheterocycles
App 20080318935 - Beckett; R. Paul ;   et al.
2008-12-25
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
Grant 7,423,156 - Smith , et al. September 9, 2
2008-09-09
Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives for the Treatment of Obesity
App 20070265298 - Smith; Roger ;   et al.
2007-11-15
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
App 20060194859 - Smith; Roger ;   et al.
2006-08-31
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
Grant 7,091,228 - Smith , et al. August 15, 2
2006-08-15
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20050215594 - O'Connor, Stephen J. ;   et al.
2005-09-29
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Grant 6,919,371 - O'Connor , et al. July 19, 2
2005-07-19
Sulfonamide substituted chroman derivatives
Grant 6,903,218 - Ladouceur , et al. June 7, 2
2005-06-07
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
App 20040224997 - Smith, Roger ;   et al.
2004-11-11
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-.gamma. binding agents
Grant 6,787,651 - Stolle , et al. September 7, 2
2004-09-07
Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
App 20040072843 - Ladouceur, Gaetan H. ;   et al.
2004-04-15
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20040072828 - O'Connor, Stephen J. ;   et al.
2004-04-15
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
Grant 6,699,860 - Ladouceur , et al. March 2, 2
2004-03-02
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Grant 6,660,752 - O'Connor , et al. December 9, 2
2003-12-09
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
App 20030087902 - Stolle, Andreas ;   et al.
2003-05-08
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
App 20030078258 - Ladouceur, Gaetan H. ;   et al.
2003-04-24
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20030078260 - O'Connor, Stephen J. ;   et al.
2003-04-24
Company Registrations
SEC0001453970Campbell Ann Marie

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed